Investors looking for stocks in the Technology Services sector might want to consider either Smiths Group PLC (SMGZY) or Cellebrite DI Ltd. (CLBT). But which of these two companies is the best option ...

Cellebrite DI Ltd. (CLBT) has been on a downward spiral lately with significant selling pressure. After declining 17.6% over ...

Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) has received an average recommendation of “Buy” from the eight research ...

Cellebrite DI Ltd. (NASDAQ:CLBT – Get Free Report) fell 7.2% on Thursday following a weaker than expected earnings announcement. The company traded as low as $21.80 and last traded at $23.13.

Lake Street analyst Eric Martinuzzi raised the firm’s price target on Cellebrite (CLBT) to $26 from $21 and keeps a Buy rating on the shares.

Since announcing its intent to pursue FedRAMP authorization, the Cellebrite Government Cloud was reviewed by a Third-Party Assessment Organization (3PAO), and the FedRAMP Program Management Office ...

CLBT's ambitious financial targets include 24% CAGR in ARR and 20% CAGR in total revenues by 2028, with significant margin improvements since 2022. Despite a potential short-term sell-off ...

In my opinion, Cellebrite DI (NASDAQ:CLBT) is the most promising play in the digital forensics space. The company offers the opportunity for extremely high barriers to entry and switching costs in ...

CELLEBRITE DI ($CLBT) posted quarterly earnings results on Thursday, February 13th. The company reported earnings of $0.10 per share, missing estimates of $0.10 by $0 ...